Riik: Malaisia
keel: inglise
Allikas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
TYLOSIN TARTRATE
F.E. VENTURE SDN. BHD.
TYLOSIN TARTRATE
150 gm
Nam Pharma Sdn. Bhd.
TYLOSINA 66.8% W/W WATER SOLUBLE POWDER (FOR VETERINARY USE ONLY) COMPOSITION Tylosin Tartrate ……………..……………… 668g (Tylosin activity……………………………607g) Excipients q.s.………………………….…….1000g PRODUCT DESCRIPTION It is a light yellow color powder. PHARMACODYNAMICS Tylosin is a macrolide antibiotic produced by a strain of _ Streptomyces fradiae_. It exerts its antimicrobial effect by inhibiting protein synthesis of susceptible micro-organisms. The tylosin spectrum of activity includes Gram-positive bacteria including _Clostridium perfringens_ and some Gram-negative strains such as Pasteurella and Mycoplasma spp_. _at concentrations of 16µg/ml or less. PHARMACOKINETICS Absorption: Tylosin reaches maximal blood levels between 1 and 3 hours after an oral dose. Minimal or no blood levels remain 24 hours after an oral dose. Distribution: After oral doses were given to pigs, tylosin was found in all tissues, between 30 minutes and two hours after administration, except for the brain and spinal cord. Biotransformation and Elimination: It has been shown that most of the material which is excreted is to be found in the faeces and consists of tylosin (factor A), relomycin (factor D) and dihydrodesmycosin. INDICATIONS Chickens: For the control of _Mycoplasma synoviae_ airsacculitis and _Mycoplasma gallisepticum_ S6 in chickens. In the field tylosin has also proved useful in reducing the level of infection following stress associated with live vaccination. As an aid in the control of outbreaks of necrotic enteritis in chickens caused by _Clostridium perfringens_. Pigs: For the prevention and control of enzootic pneumonia, and scours caused by organisms (e.g. _Lawsonia intracellularis_) sensitive to tylosin CONTRA-INDICATIONS Do not leave or dispose of water containing tylosin tartrate where it may be accessible to either animals not under treatment or to wildlife. Do not use in known cases of hypersensitivity to tylosin or other macrolides. MODE OF ADMINISTRATION Oral Lugege kogu dokumenti